Endo International plc announced that it received U.S. Food and Drug Administration (FDA) approval of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to...
Cynosure announced the U.S., European and Australian launch of the Elite iQ™ platform, the next generation of the Elite+™ Aesthetic Workstation that allows for...
The FDA has approved SciBase AB's Nevisense 3.0, the third generation of their Nevisense system for early melanoma detection. Nevisense, an AI-based...
Medical aesthetics company Cynosure has secured approval from the US Food and Drug Administration (FDA) for its Potenza radiofrequency (RF) microneedling device.
Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology pioneer focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection...
Dr. Michael Omidi, M.D., F.A.C.S., is a double-board certified plastic surgeon practicing in Beverly Hills and greater Los Angeles specializing in cosmetic surgery....